Globus Medical, Inc. (GMED)

Market Cap	10.93B
Revenue (ttm)	2.52B
Net Income (ttm)	102.98M
Shares Out	136.17M
EPS (ttm)	0.75
PE Ratio	107.04
Forward PE	23.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,234,663
Open	82.82
Previous Close	84.12
Day's Range	79.50 - 82.82
52-Week Range	49.33 - 94.93
Beta	1.19
Analysts	Buy
Price Target	96.91 (+20.72%)
Earnings Date	Feb 20, 2025

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, tot...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 3, 2012
• Employees: 5,000
• Stock Exchange: NYSE
• Ticker Symbol: GMED
• Website: https://www.globusmedical.com

Financial Performance

In 2024, Globus Medical's revenue was $2.52 billion, an increase of 60.62% compared to the previous year's $1.57 billion. Earnings were $102.98 million, a decrease of -16.19%.

Analyst Forecast

According to 12 analysts, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $96.91, which is an increase of 20.72% from the latest price.

Price Target

$96.91

(20.72% upside)

Analyst Consensus: Buy